Author | Jill Wechsler, Pharm Exec's Washington Correspondent

Jill Wechsler is Pharm Exec's Washington Corespondent


Early Vaccine Authorization Raises Ethical & Logistical Challenges for Trial Sponsors

This week's much-anticipated meeting of FDA’s vaccine advisory committee will address critical issues related to the testing and approval of vaccines to prevent COVID-19 infection.

Industry Backs Clear FDA Standards for COVID Vaccine Authorization

FDA has published updated Emergency Use Authorization (EUA) requirements for new coronavirus preventives.

COVID Vaccine Distribution Raises Multiple Challenges

Experts fear confusion over allocation process, cold-chain requirements, IT systems.